Limula
Lausanne, CH · 3 known investors
Limula develops an automated, closed platform for manufacturing personalized cell and gene therapies, aiming to move production from open, manual methods to scalable automated processes. It serves cell therapy developers and manufacturers in the biotech and pharmaceutical industry, and is based in Switzerland.
BiotechDeep TechHardwareMedical Devices
Founders & leadership
TE
Thomas EatonFounder & CEO
YP
Yann PiersonFounder & CTO
CB
Caroline BoudousquiéHead of Solutions
OW
Olivier WaridelHead of Operations